三氧化二砷对腺样囊性癌ACC-2细胞的端粒酶逆转录酶mRNA表达的影响
The Effect of Arsenic Trioxide on the Expression of Telomerase Reverse Transcriptase mRNA in ACC-2 Cells of Adenoid Cystic Carcinoma
DOI: 10.12677/HJO.2016.54017, PDF,    科研立项经费支持
作者: 姜 涛, 周 杨:眼科,青岛大学附属医院,山东 青岛;姜 靖:东区感染科,青岛大学附属医院,山东 青岛;王仁萍:健康查体中心,青岛大学附属医院,山东 青岛;王 毅, 肖利华:北京武警总医院眼眶病研究所,中国 北京
关键词: 三氧化二砷(As2O3)腺样囊性癌ACC-2细胞凋亡端粒酶hTERT mRNAArsenic Trioxide Adenoid Cystic Carcinoma ACC-2 Cells Apoptosis hTERT mRNA
摘要: 目的:探讨As2O3对ACC-2细胞端粒酶hTERT mRNA表达的影响。方法:进行ACC-2细胞培养,将As2O3建立不同药物浓度梯度(0、1.0、2.0、4.0、8.0 μmol/L)分别作用于ACC-2细胞24 h,48 h,应用RT-PCR方法,检测As2O3作用前后,ACC-2细胞的hTERT mRNA表达水平。结果:RT-PCR结果显示,在未经药物作用、作为对照组的正常培养的ACC-2细胞中,hTERT mRNA呈现明显高表达;在As2O3作用于ACC-2细胞后24 h与48 h时,随As2O3药物浓度的增高(1.0 μmol/L、2.0 μmol/L、4.0 μmol/L、8.0 μmol/L),hTERT mRNA表达逐渐降低(P < 0.01)。结论:As2O3可下调ACC-2细胞的hTERT mRNA转录表达,来诱导ACC-2细胞凋亡。
Abstract: AIM: To investigate the effect of As2O3 on the expression of telomerase reverse transcriptase mRNA in ACC-2 cells. METHODS: ACC-2 cells were cultured. The different drug concentration gradient (0, 1.0, 2.0, 4.0, 8.0 μmol/L) of As2O3 were applied to ACC-2 cells for 24 h and 48 h respectively. The hTERT mRNA expression of ACC-2 cells before and after As2O3’s induction was detected by RT-PCR. RESULTS: RT-PCR results showed that hTERT mRNA expression was significantly higher in the control group, while after As2O3 action to ACC-2 cell for 24 h and 48 h, with the increase of As2O3 concentration (1.0 μmol/L, 2.0 μmol/L, 4.0 μmol/L, 8.0 μmol/L), hTERT mRNA expression decreased gradually (P < 0.01). CONCLUSION: As2O3 can induce apoptosis of ACC-2 cells by downregulating hTERT mRNA transcript expression.
文章引用:姜涛, 姜靖, 周杨, 王仁萍, 王毅, 肖利华. 三氧化二砷对腺样囊性癌ACC-2细胞的端粒酶逆转录酶mRNA表达的影响[J]. 眼科学, 2016, 5(4): 95-104. https://dx.doi.org/10.12677/HJO.2016.54017

参考文献

[1] Jaso, J. and Malhotra, R. (2011) Adenoid Cystic Carcinoma. Archives of Pathology & Laboratory Medicine, 135, 511- 515.
[2] Boukheris, H., Curtis, R.E., Land, C.E. and Dores, G.M. (2009) Incidence of Carcinoma of the Major Salivary Glands according to the WHO Classification, 1992 to 2006: A Population-Based Study in the United States. Cancer Epidemiology, Biomarkers & Prevention, 18, 2899-2906.[CrossRef
[3] Saito, M., Nishiyama, H., Maruyama, S., Oda, Y., Saku, T. and Hayashi, T. (2008) Adenoid Cystic Carcinoma of Sublingual Gland Involving the Submandibular Duct. Dentomaxillofacial Radiology, 37, 421-424. [Google Scholar] [CrossRef] [PubMed]
[4] Al-Khateeb, T.H. and Ababneh, K.T. (2007) Salivary Tumors in North Jordanians: A Descriptive Study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 103, e53-59. http://www.ncbi.nlm.nih.gov/pubmed/?term=Salivary+tumors+in+north+Jordanians%3A+a+descriptive+study [Google Scholar] [CrossRef] [PubMed]
[5] de Oliveira, F.A., Duarte, E.C., Taveira, C.T., Máximo, A.A., de Aquino, E.C., Alencar Rde, C. and Vencio, E.F. (2009) Salivary Gland Tumor: A Review of 599 Cases in a Brazilian Population. Head and Neck Pathology, 3, 271-275. [Google Scholar] [CrossRef] [PubMed]
[6] Fujii, Y., Masuda, M., Hirokawa, M., Matsushita, K. and Hasegawa, H. (1991)
Bilateral Renal Metastases of Lung Adenoid Cystic carcinoma. Hinyokika Kiyo, 37, 1307-1311.
http://www.ncbi.nlm.nih.gov/pubmed/1661561
[7] Campistron, M., Rouquette, I., Courbon, F., Chabbert, V., Rochaix, P., Prévot, G., Laroumagne, S., Têtu, L., Didier, A. and Mazières, J. (2008) Adenoid Cystic Carcinoma of the Lung: Interest of 18FDG PET/CT in the Management of an Atypical Presentation. Lung Cancer, 59, 133-136. http://www.ncbi.nlm.nih.gov/pubmed/?term=Adenoid+cystic+carcinoma+of+the+lung%3A+interest+of+18FDG+PET%2FCT+in+the+management+of+an+atypical+presentation [Google Scholar] [CrossRef] [PubMed]
[8] Yurut-Caloglu, V., Caloglu, M., Ozyilmaz, F., Saynak, M., Cosar-Alas, R., Karagol, H., Bayir-Angin, G. and Uzal, C. (2007) Lung, Bone, Skeletal Muscles and Cutaneous Metastases from Adenoid Cystic Carcinoma of the Parotid Gland: A Case Report and Review of the Literature. Medical Oncology, 24, 458-462. http://www.ncbi.nlm.nih.gov/pubmed/?term=Lung%2C+bone%2C+skeletal+muscles+and+cutaneous+metastases+from+adenoid+cystic+carcinoma+of+the+parotid+gland%3A+a+case+report+and+review+of+the+literature [Google Scholar] [CrossRef] [PubMed]
[9] Yokouchi, H., Otsuka, Y., Otoguro, Y., Takemoto, N., Ito, K., Uchida,
Y., Okamoto, K., Nishimura, M., Kimura, K. and Kaji, H. (2007) Primary Peripheral Adenoid
Cystic Carcinoma of the Lung and Literature Comparison of Features. Internal Medicine, 46, 1799-1803.
http://www.ncbi.nlm.nih.gov/pubmed/?term=Primary+peripheral+adenoid+
cystic+carcinoma+of+the+lung+and+literature+comparison+of+features
[10] Aubry, M.C., Heinrich, M.C., Molina, J., Lewis, J.E., Yang, P., Cassivi, S.D. and Corless, C.L. (2007) Primary Adenoid Cystic Carcinoma of the Lung: Absence of KIT Mutations. Cancer, 110, 2507-2510. http://www.ncbi.nlm.nih.gov/pubmed/?term=Primary+adenoid+cystic+carcinoma+of+the+lung%3A+absence+of+KIT+mutations [Google Scholar] [CrossRef] [PubMed]
[11] Haresh, K.P., Prabhakar, R., Rath, G.K., Sharma, D.N., Julka, P.K. and Subramani, V. (2008) Adenoid Cystic Carcinoma of the Trachea Treated with PET-CT Based Intensity Modulated Radiotherapy. Journal of Thoracic Oncology, 3, 793-795. [Google Scholar] [CrossRef
[12] Counter, C.M. (1996) The Roles of Telomeres and Telomerase in Cell Life Span. Mutation Research, 366, 45-63. http://www.ncbi.nlm.nih.gov/pubmed/8921986 [Google Scholar] [CrossRef
[13] Kirkpatrick, K.L. and Mokbel, K. (2001) The Significance of Human Telomerase Reverse Transcriptase (hTERT) in Cancer. European Journal of Surgical Oncology, 27, 754-760. http://www.ncbi.nlm.nih.gov/pubmed/11735173 [Google Scholar] [CrossRef] [PubMed]
[14] Ducrest, A.L., Szutorisz, H., Lingner, J. and Nabholz, M. (2002) Regulation of the Human Telomerase Reverse Transcriptase Gene. Oncogene, 21, 541-552. http://www.ncbi.nlm.nih.gov/pubmed/?term=Ducrest+AL%2C+Szutorisz+H%2C+Lingner+J%2C+Nabholz+M [Google Scholar] [CrossRef] [PubMed]
[15] 欧阳艳艳, 姜涛, 高萌, 肖利华, 周杨, 顿月丽,
赵桂秋, 刘世海, 梁晔. △ψm和Caspase 3在As2O3诱导腺样
囊性癌ACC-2细胞凋亡过程中的作用[J]. 国际眼科杂志, 2014, 14(2): 232-235.
[16] Bougel, S., Renaud, S., Braunschweig, R., Loukinov, D., Morse, H.C., Bosman, F.T., Lobanenkov, V. and Benhattar, J. (2010) PAX5 Activates the Transcription of the Human Telomerase Reverse Transcriptase Gene in B Cells. Journal of Pathology, 220, 87-96. [Google Scholar] [CrossRef] [PubMed]
[17] Dowdy, S.C., O’Kane, D.J., Keeney, G.L., Boyd, J. and Podratz, K.C. (2001) Telomerase Activity in Sex Cord- Stromal Tumors of the Ovary. Gynecologic Oncology, 82, 257-260. http://www.ncbi.nlm.nih.gov/pubmed/?term=Telomerase+activity+in+sex+cord-stromal+tumors+of+the+ovary [Google Scholar] [CrossRef] [PubMed]
[18] Riou, L., Bastos, H., Lassalle, B., Coureuil, M., Testart, J., Boussin, F.D., Allemand, I. and Fouchet, P. (2005) The Telomerase Activity of Adult Mouse Testis Resides in the Spermatogonial Alpha6-Integrin-Positive Side Population Enriched in Germinal Stem Cells. Endocrinology, 146, 3926-3932. http://www.ncbi.nlm.nih.gov/pubmed/?term=The+telomerase+activity+of+adult+mouse+testis+resides+in+the+spermatogonial+alpha6-integrin-positive+side+population+enriched+in+germinal+stem+cells [Google Scholar] [CrossRef] [PubMed]
[19] Misiti, S., Nanni, S., Fontemaggi, G., Cong, Y.S., Wen, J., Hirte, H.W., Piaggio, G., Sacchi, A., Pontecorvi ,A., Bacchetti, S. and Farsetti, A. (2000) Induction of hTERT Expression and Telomerase Activity by Estrogens in Human Ovary Epithelium Cells. Molecular and Cellular Biology, 20, 3764-3771. http://www.ncbi.nlm.nih.gov/pubmed/?term=Induction+of+hTERT+expression+and+telomerase+activity+by+estrogens+in+human+ovary+epithelium+cells [Google Scholar] [CrossRef
[20] Gan, Y., Mo, Y., Johnston, J., Lu, J., Wientjes, M.G. and Au, J.L. (2002) Telomere Maintenance in Telomerase-Posi- tive Human Ovarian SKOV-3 Cells Cannot Be Retarded by Complete Inhibition of Telomerase. FEBS Letters, 527, 10-14. http://www.ncbi.nlm.nih.gov/pubmed/?term=Telomere+maintenance+in+telomerase-positive+human+ovarian+SKOV-3+cells+cannot+be+retarded+by+complete+inhibition+of+telomerase [Google Scholar] [CrossRef
[21] Nakajima, A., Tauchi, T., Sashida, G., Sumi, M., Abe, K., Yamamoto, K., Ohyashiki, J.H. and Ohyashiki, K. (2003) Telomerase Inhibition Enhances Apoptosis in Human Acute Leukemia Cells: Possibility of Antitelomerase Therapy. Leukemia, 17, 560-567. http://www.ncbi.nlm.nih.gov/pubmed/?term=Telomerase+inhibition+enhances+apoptosis+in+human+acute+leukemia+cells%3A+possibility+of+antitelomerase+therapy [Google Scholar] [CrossRef] [PubMed]
[22] Kammori, M., Izumiyama, N., Hashimoto, M., Nakamura, K., Okano, T., Kurabayashi, R., Naoki, H., Honma, N., Ogawa, T., Kaminishi, M. and Takubo, K. (2005) Expression of Human Telomerase Reverse Transcriptase Gene and Protein, and of Estrogen and Progesterone Receptors, in Breast Tumors: Preliminary Data from Neo-Adjuvant Chemotherapy. International Journal of Oncology, 27, 1257-1263. http://www.ncbi.nlm.nih.gov/pubmed/?term=Expression+of+human+telomerase+reverse+transcriptase+gene+and+protein%2C+and+of+estrogen+and+progesterone+receptors%2C+in+breast+tumors%3A+preliminary+data+from+neo-adjuvant+chemotherapy [Google Scholar] [CrossRef
[23] Sanz-Casla, M.T., Vidaurreta, M., Sanchez-Rueda, D., Maestro, M.L., Arroyo, M. and Cerdán, F.J. (2005) Telomerase Activity as a Prognostic Factor in Colorectal Cancer. Onkologie, 28, 553-557. http://www.ncbi.nlm.nih.gov/pubmed/16249640 [Google Scholar] [CrossRef] [PubMed]
[24] Hsu, C.P., Ko, J.L., Shai, S.E. and Lee, L.W. (2007) Modulation of Telomere Shelterin by TRF1 [Corrected] and TRF2 Interacts with Telomerase to Maintain the Telomere Length in Non-Small Cell Lung Cancer. Lung Cancer, 58, 310- 316. http://www.ncbi.nlm.nih.gov/pubmed/?term=Modulation+of+telomere+shelterin+by+TRF1+%5Bcorrected%5D+and+TRF2+interacts+with+telomerase+to+maintain+the+telomere+length+in+non-small+cell+lung+cancer [Google Scholar] [CrossRef] [PubMed]
[25] Hartmann, D., Srivastava, U., Thaler, M., Kleinhans, K.N., N’kontchou, G., Scheffold, A., Bauer, K., Kratzer, R.F., Kloos, N., Katz, S.F., Song, Z., Begus-Nahrmann, Y., Kleger, A., von Figura, G., Strnad, P., Lechel, A., Günes, C., Potthoff, A., Deterding, K., Wedemeyer, H., Ju, Z., Song, G., Xiao, F., Gillen, S., Schrezenmeier, H., Mertens, T., Ziol, M., Friess, H., Jarek, M., Manns, M.P., Beaugrand, M. and Rudolph, K.L. (2011) Telomerase Gene Mutations Are Associated with Cirrhosis Formation. Hepatology, 53, 1608-1617. [Google Scholar] [CrossRef] [PubMed]
[26] Calado, R.T., Regal, J.A., Kleiner, D.E., Schrump, D.S., Peterson, N.R., Pons, V., Chanock, S.J., Lansdorp, P.M. and Young, N.S. (2009) A Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations. PLoS ONE, 4, e7926. [Google Scholar] [CrossRef] [PubMed]
[27] Pendino, F., Tarkanyi, I., Dudognon, C., Hillion, J., Lanotte, M., Aradi, J. and Ségal-Bendirdjian, E. (2006) Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies? Current Cancer Drug Targets, 6, 147-180. http://www.ncbi.nlm.nih.gov/pubmed/16529544 [Google Scholar] [CrossRef] [PubMed]
[28] Swanberg, S.E., Payne, W.S., Hunt, H.D., Dodgson, J.B. and Delany, M.E. (2004) Telomerase Activity and Differential Expression of Telomerase Genes and c-Myc in Chicken Cells in Vitro. Developmental Dynamics, 231, 14-21. http://www.ncbi.nlm.nih.gov/pubmed/?term=Telomerase+activity+and+differential+expression+of+telomerase+genes+and+c-myc+in+chicken+cells+in+vitro [Google Scholar] [CrossRef] [PubMed]
[29] Bhattacharyya, S., Keirsey, J., Russell, B., Kavecansky, J., Lillard-Wetherell, K., Tahmaseb, K., Turchi, J. and Groden, J. (2009) Telomerase-Associated Protein 1, HSP90, and Topoisomerase IIAlpha Associate Directly with the BLM Helicase in Immortalized Cells Using ALT and Modulate Its Helicase Activity Using Telomeric DNA Substrates. Journal of Biological Chemistry, 284, 14966-14977. [Google Scholar] [CrossRef
[30] Kim, H.R., Christensen, R., Park, N.H., Sapp, P., Kang,
M.K. and Park, N. (2001) Elevated Expression of hTERT Is Associated with Dysplastic
Cell Transformation during Human Oral Carcinogenesis in Situ. Clinical Cancer Research, 7, 3079-3086.
http://www.ncbi.nlm.nih.gov/pubmed/11595698
[31] Xu, D., Popov, N., Hou, M., Wang, Q., Bjrkholm, M., Gruber, A., Menkel, A. and Henriksson, M. (2001) Switch from Myc/Max to Mad1/Max Binding and Decrease in Histone Acetylation at the Telomerase Reverse Transcriptase Promoter during Differentiation of HL60 Cells. Proceedings of the National Academy of Sciences of the United States of America, 98, 3826-3831. http://www.ncbi.nlm.nih.gov/pubmed/?term=Switch+from+Myc%2FMax+to+Mad1%2FMax+binding+and+decrease+in+histone+acetylation+at+the+telomerase+reverse+transcriptase+promoter+during+differentiation+of+HL60+cells [Google Scholar] [CrossRef] [PubMed]
[32] Bashash, D., Ghaffari, S.H., Zaker, F., Hezave, K., Kazerani, M., Ghavamzadeh, A., Alimoghaddam, K., Mosavi, S.A., Gharehbaghian, A. and Vossough, P. (2012) Direct Short-Term Cytotoxic Effects of BIBR 1532 on Acute Promyelocytic Leukemia Cells through Induction of p21 Coupled with Downregulation of c-Myc and hTERT Transcription. Cancer Investigation, 30, 57-64. [Google Scholar] [CrossRef] [PubMed]
[33] Huang, S.T., Wang, C.Y., Yang, R.C., Chu, C.J., Wu, H.T. and Pang, J.H. (2010) Wogonin, an Active Compound in Scutellaria baicalensis, Induces Apoptosis and Reduces Telomerase Activity in the HL-60 Leukemia Cells. Phytomedicine, 17, 47-54. [Google Scholar] [CrossRef] [PubMed]
[34] Park, S.E., Yoo, H.S., Jin, C.Y., Hong, S.H., Lee, Y.W., Kim, B.W., Lee, S.H., Kim, W.J., Cho, C.K. and Choi, Y.H. (2009) Induction of Apoptosis and Inhibition of Telomerase Activity in Human Lung Carcinoma Cells by the Water Extract of Cordyceps militaris. Food and Chemical Toxicology, 47, 1667-1675. [Google Scholar] [CrossRef] [PubMed]
[35] Yang, S.M., Fang, D.C., Yang, J.L., Chen, L., Luo, Y.H. and Liang, G.P. (2008) An-tisense Human Telomerase Reverse Transcriptase Could Partially Reverse Malignant Phenotypes of Gastric Carcinoma Cell Line in Vitro. European Journal of Cancer Prevention, 17, 209-217. [Google Scholar] [CrossRef